MD1568G2 - Method of treatment of the burn disease in the burn shock period - Google Patents

Method of treatment of the burn disease in the burn shock period

Info

Publication number
MD1568G2
MD1568G2 MDA20000058A MD20000058A MD1568G2 MD 1568 G2 MD1568 G2 MD 1568G2 MD A20000058 A MDA20000058 A MD A20000058A MD 20000058 A MD20000058 A MD 20000058A MD 1568 G2 MD1568 G2 MD 1568G2
Authority
MD
Moldova
Prior art keywords
burn
hours
treatment
chloridephysiologic
rest
Prior art date
Application number
MDA20000058A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD1568F1 (en
Inventor
Василие ЛУТАН
Oleg Galbur
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDA20000058A priority Critical patent/MD1568G2/en
Publication of MD1568F1 publication Critical patent/MD1568F1/en
Publication of MD1568G2 publication Critical patent/MD1568G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, namely to burn disease treatment in the burn shock period.Summary of the invention consists in application on the burn wound of the bandage moistened with the mixture of medical remedies of following composition, mg/100 ml :hyaluronic acid 500…1000furacin 20…40novocaine 1000…1500dimedrol 80…160dexamethasone 8…16heparin 5000…10000 UIcontical 5000…10000 UIsodium chloridephysiologic solution the rest.The bandage is applied to the burn wound in 6-10 hours during 48 hours and at the same time it is carried out the parenteral treatment including the administration of medical remedies composition at the following component ratio, mg/100 ml:hyaluronic acid 500…1000dexamethason 8…16glucose 5000…8000sodium chloridephysiologic solution the rest,which is administered intraperitoneal in 10 hours in the dose of 25 ml/kg during 48 hours.
MDA20000058A 2000-03-28 2000-03-28 Method of treatment of the burn disease in the burn shock period MD1568G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20000058A MD1568G2 (en) 2000-03-28 2000-03-28 Method of treatment of the burn disease in the burn shock period

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20000058A MD1568G2 (en) 2000-03-28 2000-03-28 Method of treatment of the burn disease in the burn shock period

Publications (2)

Publication Number Publication Date
MD1568F1 MD1568F1 (en) 2000-12-31
MD1568G2 true MD1568G2 (en) 2001-06-30

Family

ID=19739571

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20000058A MD1568G2 (en) 2000-03-28 2000-03-28 Method of treatment of the burn disease in the burn shock period

Country Status (1)

Country Link
MD (1) MD1568G2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD481Z (en) * 2011-08-09 2012-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for treating I-IIIA-degree burns
JP2021046356A (en) * 2019-09-17 2021-03-25 ジャパンメディック株式会社 Therapeutic for dry skin with itch

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2449795C1 (en) * 2010-11-16 2012-05-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Method of treating chronic pancreatitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Е.Е Ягурский. Термические ожоги, Ташкент, Медицина, 1986, с. 68, 91-93 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD481Z (en) * 2011-08-09 2012-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for treating I-IIIA-degree burns
JP2021046356A (en) * 2019-09-17 2021-03-25 ジャパンメディック株式会社 Therapeutic for dry skin with itch

Also Published As

Publication number Publication date
MD1568F1 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
Waldhauser et al. Efficiency and side effects of prostaglandin El in the treatment of erectile dysfunction
ES2164040T1 (en) USE OF AGONISTS OF THE GLICINE UNION SITE OR INHIBITORS OF GLYCIN ABSORPTION FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS.
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
RU2002127804A (en) MEDICINAL SYSTEM FOR TREATMENT OF COMPLICATIONS CONNECTED WITH DIABETES AND NEUROPATHY, AND THEIR APPLICATION
ATE267798T1 (en) COMBINED ACTIVE INGREDIENTS AS A METHOD FOR TARGETED ACTIVE RELEASE
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
CA2503810A1 (en) Therapeutic agent for fibromyalgia
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
JP2002528502A5 (en)
JP2001510795A5 (en)
JP2004507496A5 (en)
JP2004537500A5 (en)
RU95101385A (en) Products containing g-csf and tnf-binding protein
CA2401000A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
MXPA05005781A (en) Combination of ibuprofen and oxycodone for acute pain relief.
MY124465A (en) Reduction of infarct volume using citicoline
JP2003514025A5 (en)
JP2003503453A5 (en) Synergistic composition comprising gabapentin and pregabalin
MD1568G2 (en) Method of treatment of the burn disease in the burn shock period
Cassuto et al. Potent inhibition of burn pain without use of opiates
WO1996030016A3 (en) Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
CA2516458A1 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
CA2414352A1 (en) Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
AR062894A1 (en) FORMULATIONS FOR THERAPEUTIC ESTIMULATION HORMONE THERAPEUTIC ADMINISTRATION (THS)
RU1803119C (en) Method of extrauterine pregnancy treatment